Skip Ribbon Commands
Skip to main content
Navigate Up
Sign In
 
 

 Latest News

 
9/19/2014
On September 18, 2014, Pharmerit and IPAM jointly hosted a successful workshop in Berlin.
8/29/2014
We are excited to be present at the 2014 ISPOR EU conference in the capital of one of our home countries: Amsterdam.
6/23/2014
Adalimumab is cost effective in treating Spanish patients with non-radiographic axial spondyloarthritis and elevated CRP and/or positive MRI.
6/12/2014
In the first study examining pHF-W vs. CMF in an Asian country, Pharmerit, Nestlé Nutrition and affiliates found pHF-W to be a cost effective alternative for atopic dermatitis.
5/15/2014
Guideline-recommended treatments for PHN are more effective vs. placebo. Additional evaluations for less common NeP conditions are required, despite published treatment guidelines.
4/28/2014
Anastomotic leaks—one of the surgical complications following colorectal surgeries—are associated with significant economic burden in the United States, including significantly extended hospital stays and excess medical costs.
4/15/2014
The risks of BSIs vary according to the type of parental nutrition provided. The safest approach, consisting of ready-to-use three-chamber bag (MCB), was also shown to be essentially cost neutral.
4/10/2014
For oral medications with restrictions, understanding physician and patient knowledge gaps is critical to ensuring patients receive appropriate medication directions.
4/4/2014
​BETHESDA, MD, USA. April 2, 2014 -- Pharmerit International is pleased to announce the recent publication of a research paper conducted by Pharmerit International authors Caitlyn Solem
3/24/2014
Pharmerit-coauthored systematic literature review reveals important gaps in the definition, measurement, prevalence, outcomes, and risk factors of non-adherence to BCR-ABL inhibitors in leukemia.
Contact Feel free to contact us if you have any questions
Year
 
News category